Cargando…
COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia
BACKGROUND: Studies of mRNA and vector-based vaccines used in different countries report acceptable levels of effectiveness against SARS-CoV-2 infection caused by the Delta variants of SARS-CoV-2. No studies estimated vaccine effectiveness (VE) of Gam-COVID-Vac and other vaccines used in Russia agai...
Autores principales: | Barchuk, Anton, Bulina, Anna, Cherkashin, Mikhail, Berezina, Natalia, Rakova, Tatyana, Kuplevatskaya, Darya, Stanevich, Oksana, Skougarevskiy, Dmitriy, Okhotin, Artemiy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503256/ https://www.ncbi.nlm.nih.gov/pubmed/36138385 http://dx.doi.org/10.1186/s12889-022-14202-9 |
Ejemplares similares
-
Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study
por: Barchuk, Anton, et al.
Publicado: (2022) -
Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case–control study
por: Barchuk, Anton, et al.
Publicado: (2022) -
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
por: Barchuk, Anton, et al.
Publicado: (2021) -
COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data
por: Barchuk, Anton, et al.
Publicado: (2022) -
Epidemic of Plague in St. Petersburg, Russia
Publicado: (1865)